Back to All Events

Vaccines and Related Biological Products Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

The USFDA has scheduled a Vaccines and Related Biological Products Advisory Committee [VRBPAC] meeting for October 5, 2023. During the meeting, the committee will discuss the Strain Selection for the Influenza Virus Vaccines for the 2024 Southern Hemisphere Influenza Season.